Company news
Quantum Biopharma Ltd. Subordinate Voting Shares news in 2019
Quantum Biopharma Ltd. Subordinate Voting Shares's news releases, calls and decks from 2019, newest first.
FSD Pharma Receives Approval to List its Shares on Nasdaq
December 16, 2019
FSD Pharma to Present at Investor Summit on December 17
December 13, 2019
FSD Pharma to Present at 12th Annual LD Micro Main Event Investor Conference on December 11
December 5, 2019
FSD Pharma Reports Third Quarter 2019 Financial Results
November 29, 2019
FSD Pharma Second Tranche of Private Placement Closes, Total of $4.59 Million Raised at $20.10 To Date, Extends Offering
November 4, 2019
FSD Pharma Announces the Filing of an Amended Annual MD&A for 2018
October 23, 2019
FSD Pharma Announces Temporary Change in OTCQB Ticker Symbol to FSDDD
October 17, 2019
FSD Pharma Appoints Former Member of U.S. Congress to its Board of Directors, Announces Share Consolidation
October 11, 2019
FSD Pharma Closes First Tranche of Private Placement at $4.58 Million, Extends Offering
October 1, 2019
InvestmentPitch Media Video Discusses FSD Pharma's LOI with World Class Extractions Creating JV to Build and Operate Cannabis Extraction/Processing Facility in Cobourg, Ontario - Video Available on Investmentpitch.com
September 26, 2019
FSD Pharma Signs LOI to Establish Joint Venture with World-Class Extractions to Deploy Full Extraction Processing Center
September 25, 2019
FSD Pharma Joins The Stock Day Podcast to Discuss Their Expanding Revenue Potential
September 12, 2019
FSD Pharma Announces Private Placement
August 30, 2019
FSD Pharma Launches Online Ordering System for Medicinal Cannabis Fulfillment
August 21, 2019
FSD Pharma Closes Deal to Acquire Prismic Pharmaceuticals
July 2, 2019
FSD Pharma Receives Full "Sale for Medical Purposes" Cannabis License from Health Canada
June 24, 2019
FSD Pharma Continues to Add Expert Advisors Amid Buildout of Massive Facility -- CFN Media
June 14, 2019
FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors
June 12, 2019
FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board
June 6, 2019
FSD Pharma Brings in World-Renowned Experts to Build Bioscience Division -- CFN Media
June 4, 2019
Dr. Raza Bokhari, FSD Pharma Executive Co-Chairman and CEO to Participate in Biotech-Focused Panel at the 2019 BIO International Convention
June 3, 2019
FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta
May 31, 2019
Edward Brennan, Jr., M.D., FACS to Lead FSD Pharma BioSciences Division
May 28, 2019
FSD Pharma Welcomes All-Star Lineup of Cannabis Researchers to Scientific Advisory Board
May 20, 2019
FSD Pharma CEO Lays Out Roadmap in Exclusive Interview with CFN Media
May 10, 2019
FSD Pharma Investments Pay Off Amid Robust Expansion at Ontario Facility -- CFN Media
May 8, 2019
FSD Pharma Announces Research Agreement with Solarvest to Develop Algae-based, Pharma-grade Cannabinoids
May 7, 2019
FSD Pharma Reports 2018 Year-End Results
May 6, 2019
FSD Pharma provides update on status of 2018 year-end filings
May 2, 2019
FSD Pharma Doubles Down on Endocannabinoid-based Pain Management -- CFN Media
May 1, 2019
FSD Pharma and MP Kim Rudd Host Media Event at Cobourg Production Facility
April 26, 2019
FSD Pharma Announces Share Exchange Transaction with Aura Health
April 24, 2019
InvestmentPitch Media Video Discusses FSD Pharma and its New Additional License to Sell Cannabis for Medical Purposes - Video Available on Investmentpitch.com
April 23, 2019
FSD Pharma Receives Cannabis Sales License from Health Canada
April 22, 2019
FSD Pharma to Present at Arcview Investor Forum
April 17, 2019
FSD Pharma Appoints Charles Pollack Jr. MD, FACEP as Chairman of the Scientific Advisory Board
April 4, 2019